Holliston, MA 8/23/10—Harvard Bioscience has acquired substantially all the assets of Coulbourn Instruments for an undisclosed amount. Coulbourn Instruments manufactures behavioral measurement products, with an emphasis on systems for assessing learning and memory utilized in research labs. “The acquisition of Coulbourn provides us another well established brand in our portfolio of products and enables us to provide our customers a broader range of tools, expanded technical support and a strong direct sales team in the behavior research market,” said Chane Graziano, CEO of Harvard Bioscience. The acquisition is expected to be immediately accretive to earnings and to add $4 million in annual revenue.